0

President’s Message: New Alzheimer’s Drug Approval Slammed by Scientists

I’d like to share an important update on the Alzheimer’s drug, Aducanumab, marketed as Aduhelm in the US. Aduhelm is a monoclonal antibody drug which means that it mimics our own antibodies to [...]